The Economic Burden of Colorectal Cancer in Type 2 Diabetes Mellitus (T2DM) in Shanghai, China
ABSTRACT Objective This study aimed to analyze disease cost levels among colorectal cancer (CRC) patients, examining differences in disease costs between those with type 2 diabetes mellitus (T2DM) and those without T2DM while considering various demographic characteristics. Methods The study include...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-02-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.70651 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850147131639201792 |
|---|---|
| author | Zhi‐xu Zhu Yu‐xin Peng Jing‐hong Ye Yan Wei |
| author_facet | Zhi‐xu Zhu Yu‐xin Peng Jing‐hong Ye Yan Wei |
| author_sort | Zhi‐xu Zhu |
| collection | DOAJ |
| description | ABSTRACT Objective This study aimed to analyze disease cost levels among colorectal cancer (CRC) patients, examining differences in disease costs between those with type 2 diabetes mellitus (T2DM) and those without T2DM while considering various demographic characteristics. Methods The study included respondents from colorectal cancer patients diagnosed and managed within the population‐based cancer registry system of the Shanghai Municipal Center for Disease Control and Prevention from 2020 to 2022. Diabetic colorectal cancer cases were matched with nondiabetic colorectal cancer controls using propensity scores, maintaining a 1:1 ratio between cases and controls; bias for the majority of the matched variables is below 10%. Direct, indirect, and intangible costs were estimated for study subjects. Results After propensity score matching, the analysis encompassed 376 cases of T2DM‐related CRC and 376 non‐T2DM CRC cases. The T2DM group exhibited higher direct medical costs (¥57,059.65 vs. ¥48,933.93, p < 0.05), direct nonmedical costs (¥9292.45 vs. ¥7969.35), indirect costs (¥300.13 vs. ¥241.11), intangible costs (¥3601.70 vs. ¥2631.96), and total disease costs (¥70,253.93 vs. ¥59,776.36, p < 0.05) compared to the non‐T2DM group. In Stage II CRC, direct medical costs were ¥74,008.39 for the T2DM group versus ¥57,368.84 for the non‐T2DM group. Among surgical patients, direct medical costs were ¥57,658.81 for the T2DM group versus ¥1337.00 for the non‐T2DM group, and ¥49,061.52 for the non‐T2DM surgical group versus ¥1089.00 for the non‐T2DM nonsurgical group. Conclusion Colorectal cancer imposes a substantial economic burden. Patients with CRC and concurrent T2DM experience a higher economic burden compared to nondiabetic patients. Notably, individuals with both T2DM and Stage II cancer face a significantly higher economic burden, whereas surgical patients exhibit a significantly greater disease burden than nonsurgical patients. Efforts should concentrate on primary prevention and secondary prevention to alleviate the economic burden associated with colorectal cancer. |
| format | Article |
| id | doaj-art-eceb64ea64e7462d859947f23327c953 |
| institution | OA Journals |
| issn | 2045-7634 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Wiley |
| record_format | Article |
| series | Cancer Medicine |
| spelling | doaj-art-eceb64ea64e7462d859947f23327c9532025-08-20T02:27:39ZengWileyCancer Medicine2045-76342025-02-01144n/an/a10.1002/cam4.70651The Economic Burden of Colorectal Cancer in Type 2 Diabetes Mellitus (T2DM) in Shanghai, ChinaZhi‐xu Zhu0Yu‐xin Peng1Jing‐hong Ye2Yan Wei3School of Public Health Fudan University Shanghai People's Republic of ChinaSchool of Public Health Fudan University Shanghai People's Republic of ChinaHongkou District Center for Disease Control and Prevention, Shanghai Hongkou District Shanghai People's Republic of ChinaSchool of Public Health Fudan University Shanghai People's Republic of ChinaABSTRACT Objective This study aimed to analyze disease cost levels among colorectal cancer (CRC) patients, examining differences in disease costs between those with type 2 diabetes mellitus (T2DM) and those without T2DM while considering various demographic characteristics. Methods The study included respondents from colorectal cancer patients diagnosed and managed within the population‐based cancer registry system of the Shanghai Municipal Center for Disease Control and Prevention from 2020 to 2022. Diabetic colorectal cancer cases were matched with nondiabetic colorectal cancer controls using propensity scores, maintaining a 1:1 ratio between cases and controls; bias for the majority of the matched variables is below 10%. Direct, indirect, and intangible costs were estimated for study subjects. Results After propensity score matching, the analysis encompassed 376 cases of T2DM‐related CRC and 376 non‐T2DM CRC cases. The T2DM group exhibited higher direct medical costs (¥57,059.65 vs. ¥48,933.93, p < 0.05), direct nonmedical costs (¥9292.45 vs. ¥7969.35), indirect costs (¥300.13 vs. ¥241.11), intangible costs (¥3601.70 vs. ¥2631.96), and total disease costs (¥70,253.93 vs. ¥59,776.36, p < 0.05) compared to the non‐T2DM group. In Stage II CRC, direct medical costs were ¥74,008.39 for the T2DM group versus ¥57,368.84 for the non‐T2DM group. Among surgical patients, direct medical costs were ¥57,658.81 for the T2DM group versus ¥1337.00 for the non‐T2DM group, and ¥49,061.52 for the non‐T2DM surgical group versus ¥1089.00 for the non‐T2DM nonsurgical group. Conclusion Colorectal cancer imposes a substantial economic burden. Patients with CRC and concurrent T2DM experience a higher economic burden compared to nondiabetic patients. Notably, individuals with both T2DM and Stage II cancer face a significantly higher economic burden, whereas surgical patients exhibit a significantly greater disease burden than nonsurgical patients. Efforts should concentrate on primary prevention and secondary prevention to alleviate the economic burden associated with colorectal cancer.https://doi.org/10.1002/cam4.70651colorectal cancereconomic burdenpropensity score matchingtype 2 diabetes mellitus |
| spellingShingle | Zhi‐xu Zhu Yu‐xin Peng Jing‐hong Ye Yan Wei The Economic Burden of Colorectal Cancer in Type 2 Diabetes Mellitus (T2DM) in Shanghai, China Cancer Medicine colorectal cancer economic burden propensity score matching type 2 diabetes mellitus |
| title | The Economic Burden of Colorectal Cancer in Type 2 Diabetes Mellitus (T2DM) in Shanghai, China |
| title_full | The Economic Burden of Colorectal Cancer in Type 2 Diabetes Mellitus (T2DM) in Shanghai, China |
| title_fullStr | The Economic Burden of Colorectal Cancer in Type 2 Diabetes Mellitus (T2DM) in Shanghai, China |
| title_full_unstemmed | The Economic Burden of Colorectal Cancer in Type 2 Diabetes Mellitus (T2DM) in Shanghai, China |
| title_short | The Economic Burden of Colorectal Cancer in Type 2 Diabetes Mellitus (T2DM) in Shanghai, China |
| title_sort | economic burden of colorectal cancer in type 2 diabetes mellitus t2dm in shanghai china |
| topic | colorectal cancer economic burden propensity score matching type 2 diabetes mellitus |
| url | https://doi.org/10.1002/cam4.70651 |
| work_keys_str_mv | AT zhixuzhu theeconomicburdenofcolorectalcancerintype2diabetesmellitust2dminshanghaichina AT yuxinpeng theeconomicburdenofcolorectalcancerintype2diabetesmellitust2dminshanghaichina AT jinghongye theeconomicburdenofcolorectalcancerintype2diabetesmellitust2dminshanghaichina AT yanwei theeconomicburdenofcolorectalcancerintype2diabetesmellitust2dminshanghaichina AT zhixuzhu economicburdenofcolorectalcancerintype2diabetesmellitust2dminshanghaichina AT yuxinpeng economicburdenofcolorectalcancerintype2diabetesmellitust2dminshanghaichina AT jinghongye economicburdenofcolorectalcancerintype2diabetesmellitust2dminshanghaichina AT yanwei economicburdenofcolorectalcancerintype2diabetesmellitust2dminshanghaichina |